# Basic Concepts of Enzyme Action

> Can an enzyme make an impossible reaction happen? No — it can only make a possible one fast. This chapter separates what a reaction *will* do (thermodynamics: ΔG, Keq) from how *fast* it does it (kinetics: the activation barrier), and shows that an enzyme touches only the second — by gripping the fleeting transition state more tightly than the substrate.

Course: Biochemistry (Enzymes & Binding). Level: university elective. About 25 minutes.
Lesson page (link this one when citing): https://stemhop.com/lessons/enzyme-action-basics/

Builds on: Water, Weak Bonds, and the Generation of Order · Protein Three-Dimensional Structure: The Sequence Sets the Shape

## What you'll learn

- Use ΔG = ΔG°′ + RT ln Q to call a reaction exergonic or endergonic under real concentrations, and connect ΔG°′ to the equilibrium constant through ΔG°′ = −RT ln Keq.
- Explain why an enzyme changes the rate of a reaction but never its ΔG, ΔG°′, or Keq, and convert a rate enhancement into kJ/mol of barrier lowered.
- Describe how an enzyme lowers the activation barrier by binding the transition state more tightly than the substrate, and tell that apart from induced fit, which is about whether the active site changes shape.
- Classify an enzyme into its EC class and tell the cofactor terms apart — coenzyme vs. metal ion, prosthetic group, apoenzyme vs. holoenzyme.

**An enzyme cannot make an impossible reaction happen. It can only make a possible one fast, by lowering the energy barrier the reaction has to cross.**

The film above opens on OMP decarboxylase, the enzyme that finishes making UMP (a building block of RNA): about 10¹⁷ times faster than the uncatalyzed step, whose half-life is 78 million years, longer than the time since the dinosaurs vanished. Why can’t a protein that strong push a reaction uphill? The film answers with two valleys, the free substrate and the free product, and a ridge between them.

> **The one idea to carry through this lesson.** An enzyme, like any catalyst, lowers only the ridge, never the two valleys. Of the valleys, the drop between them at the actual concentrations (ΔG) sets which way the reaction runs, and the drop at standard conditions (ΔG°′) sets where it stops (Keq).

## Where a reaction ends up: ΔG, ΔG°′ and Q

The currency of thermodynamics is **Gibbs free energy**, G, the energy in a system available to do work. The sign of the change, ΔG, gives the direction. A negative ΔG means the reaction releases free energy and can go forward on its own: it is **exergonic**, or spontaneous. A positive ΔG means it needs an input of energy: it is **endergonic**. Spontaneous means downhill, not quick, as uncatalyzed OMP decarboxylation shows. And exoTHERMIC is not exoGONIC: exothermic is about heat (ΔH), and a reaction can release free energy without releasing much heat.

ΔG also depends on how much product and reactant are present right now; ΔG°′ is the standard reference value, and ΔG the value for the mixture actually in the tube or the cell.

> **Equation card: Which way a reaction will run under the concentrations actually present.**
>
>     ΔG = ΔG°′ + RT ln Q
>
> In words: The actual free-energy change equals the standard one, plus RT times the natural log of the current products-to-reactants ratio.
>
> - ΔG: the actual free-energy change at the current concentrations (kJ/mol)
> - ΔG°′: the standard free-energy change: every reactant and product at 1 M, 25 °C, and pH 7 (the prime) (kJ/mol)
> - R: the gas constant, 8.314 J/(mol·K) (J/(mol·K))
> - T: temperature in kelvin; 298 K is 25 °C (K)
> - Q: the reaction quotient: products over reactants right now, in the form of Keq, each concentration in M divided by the 1 M standard (none)
>
> Sanity check: When everything is at 1 M, Q = 1, ln Q = 0, and ΔG = ΔG°′. When Q reaches Keq, ΔG = 0 and the reaction is at equilibrium.
> Try one number RT at 298 K is 0.008314 × 298 = 2.48 kJ/mol. Glucose + phosphate → glucose-6-phosphate (G6P), ΔG°′ = +13.8 kJ/mol. At illustrative cell levels (5 mM glucose, 1 mM phosphate, 0.1 mM G6P), in M: Q = [G6P] / ([glucose][phosphate]) = 0.0001 / (0.005 × 0.001) = 20, RT ln 20 = 2.48 × 3.0 = 7.4, so ΔG ≈ +21 kJ/mol, still uphill. ATP hydrolysis, ΔG°′ = −30.5 kJ/mol. At illustrative red-cell levels (ATP 2.25, ADP 0.25, phosphate 1.65 mM): Q = (0.00025 × 0.00165) / 0.00225 = 1.8 × 10⁻⁴, RT ln Q = 2.48 × (−8.6) = −21.3, so ΔG ≈ −52 kJ/mol.

So ATP hydrolysis is the textbook exergonic reaction and direct glucose-6-phosphate (G6P) formation the textbook endergonic one, in standard conditions and in the cell.

As a reaction runs, Q moves toward **Keq** and ΔG creeps toward zero; at equilibrium, going nowhere net, ΔG = 0 and Q = Keq. Put those into the card:

> **ΔG°′ = −RT ln Keq**

The more negative ΔG°′, the larger Keq: ΔG°′ < 0 means Keq > 1, and ΔG°′ > 0 means Keq < 1. Work an example: ΔG°′ = −17 kJ/mol, so Keq = e−ΔG°′/RT. Convert kJ to J first: 17,000 / (8.314 × 298) = 6.86, and e6.86 ≈ 950, roughly a thousand-to-one in favor of products. Quicker: every 5.7 kJ/mol is a factor of ten (the next section shows why), so 17 kJ/mol is about three. Because the relationship is logarithmic, a modest change in free energy moves the equilibrium a lot.

**Predict.** You add an enzyme that joins glucose directly to phosphate to a cell-like mix. Does G6P pile up?

> **Check your prediction.** No. In the cell ΔG is about +21 kJ/mol, and the enzyme cannot change that. Keq is about 0.004, so equilibrium is mostly glucose and phosphate. This mix (Q = 20) is already far past it, so the enzyme would only speed the net reaction backward, breaking G6P down. Cells make G6P with hexokinase, which runs a different reaction: glucose + ATP → G6P + ADP, ΔG°′ = +13.8 − 30.5 = −16.7 kJ/mol, downhill. That is **coupling**: a change of reaction, not a moved equilibrium.

## How fast it gets there: the height of the hill

Now the ridge, which the film animates: the enzyme opens a lower pass over the same ridge, still a highest point, and molecules cross far more often.

*Figure (AI-generated illustration).* An enzyme opens a lower pass over the same ridge. The valleys, free substrate and free product, stay exactly where they were, so the equilibrium is unchanged; only the height of the crossing, and so the speed, changes. Image: two valleys separated by a mountain ridge. A grey dashed trail crosses the ridge at a high notch; a gold trail crosses the same ridge at a lower notch, with many more travellers on it. An inset shows that the floors of both valleys stay at the same height with or without the enzyme.

Each chemical step passes through a **transition state**, written X‡, the femtosecond-lived top of the pass shown in the film: neither substrate nor product, a peak rather than a molecule you can isolate (a stable stop between two peaks is an intermediate). Its height above the substrate is the **activation energy**, ΔG‡, and it sets the rate.

> **Equation card: How the height of the barrier sets the speed of a reaction.**
>
>     k ∝ e^(−ΔG‡/RT)
>
> In words: The rate constant shrinks exponentially as the barrier rises.
>
> - k: the rate constant: how often a molecule crosses the barrier (s⁻¹)
> - ΔG‡: the activation energy: the height of the transition state above the substrate (kJ/mol)
> - R: the gas constant, 8.314 J/(mol·K) (J/(mol·K))
> - T: temperature in kelvin; 298 K is 25 °C (K)
>
> Sanity check: RT × ln 10 at 298 K is 2.48 × 2.30 = 5.7 kJ/mol. So 5.7 kJ/mol off the barrier is 10 times faster, 11.4 is 100 times faster.
> Try one number An enzyme turns over its substrate at 540 s⁻¹. Without it, the same step runs at 2.9 × 10⁻⁶ s⁻¹. Speed-up: 540 ÷ (2.9 × 10⁻⁶) = 1.9 × 10⁸, about 8.3 factors of ten. Barrier lowered: 8.27 × 5.7 ≈ 47 kJ/mol. OMP decarboxylase, at about 10¹⁷: 17 × 5.7 ≈ 97 kJ/mol.

**Predict.** The enzyme lowers the top of the ridge. What happens to the barrier for the reverse reaction, product back to substrate?

> **Check your prediction.** It falls too. Count both trips from the free substrate and the free product, the valleys the enzyme cannot move: both cross the same lowered top, so forward and reverse speed up by the same factor and their ratio, Keq, does not change. An enzyme **cannot** change ΔG, ΔG°′, or Keq; it reaches the same equilibrium sooner. (The 47 kJ/mol above is counted from the bound substrate; counted from the bound product, the reverse drop matches it only if the enzyme holds product and substrate equally tightly.)

In the explorer below, slide ΔG°′ to move the product up or down, then raise how many kJ/mol the enzyme takes off the barrier and watch which part of the curve changes and which never moves.

*Interactive on the lesson page:* Reaction-coordinate explorer

## How an enzyme lowers the top: grip the transition state

The film shows the grip. The active site, a small cleft built from amino acids brought together from distant parts of the chain, fits the distorted transition state better than the substrate. Binding releases energy (**binding energy**), and the extra that goes to the transition state comes off the climb from the bound substrate. A thermodynamic cycle (Going deeper) turns that into a rule:

> **speed-up from the bound substrate = how many times more tightly the enzyme holds the transition state than the substrate**

Written with dissociation constants, Kd (the lower the Kd, the tighter the grip): kcat / kuncat = Kd(substrate) / Kd(transition state), where kcat is the rate of the step from the bound substrate and kuncat the rate with no enzyme. The 1.9 × 10⁸ enzyme above holds its transition state about 190 million times more tightly than its substrate, worth the same 47 kJ/mol.

*Figure (AI-generated illustration).* The active site is built for the transition state, not the substrate. The extra grip on the transition state is what lowers the top of the barrier, and a stable look-alike that copies its shape binds more tightly than the real substrate. Image: the same enzyme active site, shaped like a stretched oval, holds a round substrate loosely with gaps but holds the stretched transition state snugly with many contacts. An inset shows a stable look-alike of the transition state fitting just as snugly without reacting.

**Predict.** A team designs an enzyme whose active site holds the substrate exactly as tightly as it holds the transition state. How much faster does the reaction go once the substrate is bound?

> **Check your prediction.** Not at all. The bound substrate and the top drop by the same amount, so the climb from the bound substrate is as high as before. Worse, tightening the substrate’s grip alone shrinks that speed-up: take its Kd from 1 mM to 1 µM, a thousandfold tighter, with the transition state’s grip fixed, and the ratio falls a thousandfold, so a 10⁸ speed-up becomes 10⁵. The loss bites whenever the enzyme is saturated with substrate. Enzymes hold substrates moderately and transition states extremely tightly.

Binding is not the only tool. Enzymes also hold reacting groups close together and lined up, pass protons to and from the substrate (acid-base catalysis), form brief covalent bonds with it (covalent catalysis), and use metal ions. Each makes the transition state easier to reach. On paper any speed-up can still be written as extra grip on the transition state, but covalent catalysis in particular changes the transition state itself, so the simple rule then compares two different transition states.

## The evidence: transition-state analogs bind tighter

If the active site is built for the transition state, it should grip a stable look-alike of it harder than the real substrate. Proline racemase, which interconverts the two mirror forms of proline, passes through a planar transition state, its central carbon going flat as it flips, and binds its substrate, L-proline, with a Kd of 3.6 mM. Chemists made pyrrole-2-carboxylate, a stable flat look-alike the enzyme cannot turn over.

**Predict.** Which will the enzyme hold harder, its own substrate or the flat look-alike?

> **Check your prediction.** The look-alike: Kd 0.022 mM, 160 times tighter than the substrate it actually works on. The enzyme grips the shape it is built to stabilize.

Count it: 160-fold is about 2.2 factors of ten, or 12.6 kJ/mol, small next to the 47 to 97 kJ/mol that enzymes like those above take off their barriers. An analog is an imperfect mimic of so fleeting a structure, so it captures only part of the grip; the tightest designed analogs, made for other enzymes, bind far more tightly than this one. Read 160× as a down payment, not the full account.

## A separate question: does the active site change shape?

What the active site fits best and whether it changes shape are different questions. Emil Fischer’s 1894 lock-and-key picture explained why an enzyme acts on one sugar and ignores its near-twin. But a rigid lock built for the substrate would bind the substrate most tightly, and enzymes don’t: the site fits the transition state best, an idea from Haldane (1930) and Pauling (1940s), not from the shape models.

Flexibility is the second question. In 1958 Daniel Koshland proposed **induced fit**: substrate binding changes the enzyme’s shape and brings its catalytic groups into line. His central argument was hexokinase and water (scientist panel). Later work showed that many enzymes also shift between shapes before the substrate arrives, and the substrate picks the one that fits (**conformational selection**). Real enzymes often use a mix of both.

*Figure (AI-generated illustration).* Does the active site change shape? Lock and key: a rigid site already shaped for the substrate. Induced fit: binding closes the site and lines up catalytic groups. Conformational selection: open and closed shapes interconvert first, and substrate picks the one that fits. Which shape the site fits best, the transition state, is a separate question. Image: a three-step induced-fit strip shows a substrate approaching an open enzyme cleft, the cleft's two lips closing around the bound substrate as two catalytic groups line up, and the site reopening as product leaves. One inset shows the lock-and-key model, a rigid pocket cut to the substrate's shape. A second inset shows conformational selection: open and closed forms of the enzyme interconvert, and substrate binds the closed form.

## Tight binding as a drug strategy

A molecule that binds the active site more tightly than the substrate does, and that the enzyme cannot turn over, can shut the enzyme down. Drugs shaped like a transition state exploit the same logic: they bind the active site far more tightly than the substrate does. Statins get there another way. They block 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, the rate-limiting enzyme of cholesterol synthesis. They are **competitive inhibitors** (they sit in the active site and keep the substrate out), not true transition-state analogs: part of each statin mimics the HMG part of the substrate and fills its pocket, and extra contacts nearby let the drug bind with nanomolar affinity, far more tightly than the substrate. Slowing the pathway makes the liver pull more low-density lipoprotein (LDL) cholesterol out of the blood, lowering blood cholesterol as intended. Some patients report muscle symptoms; the cause is unproven (Going deeper). Inhibitors return in [enzyme kinetics](https://stemhop.com/lessons/enzyme-kinetics/).

*Figure (AI-generated illustration).* Statins competitively inhibit HMG-CoA reductase and slow the shared biosynthetic pathway. Reduced CoQ10 and isoprenoid availability with possible mitochondrial effects is one proposed, unproven explanation for muscle symptoms; true muscle damage with a large CK rise is rare. Image: a statin occupies the substrate-binding pocket of HMG-CoA reductase while HMG-CoA remains outside. A slower shared pathway branches toward cholesterol synthesis and CoQ10 and isoprenoids. A dashed connection to a muscle-cell inset marks proposed lower availability and possible mitochondrial effects as an unproven mechanism.

## Naming enzymes and their helpers

An enzyme is a reusable catalyst, usually a protein, with one important exception: some enzymes are RNA (**ribozymes**), and the ribosome that builds every protein in your body is itself one. An enzyme’s activity depends on temperature, pH, and often on a helper molecule, and its name usually ends in *-ase*.

There are seven official classes, sorted by the chemistry they do. **Oxidoreductases** move electrons. **Transferases** move a chemical group from one molecule to another. **Hydrolases** use water to break a bond. **Lyases** add or remove groups across a double bond (simplified; Going deeper has the official definition). **Isomerases** rearrange a molecule into its isomer. **Ligases** join two molecules and usually spend ATP to do it. **Translocases**, added in 2018, move ions and molecules across membranes. Each enzyme gets a four-part EC number whose first digit is its class: hexokinase, a transferase, is EC 2.7.1.1.

**Predict.** Fumarase adds a water molecule across the double bond of fumarate. It uses water. Is it a hydrolase?

> **Check your prediction.** No, a lyase. A hydrolase uses water to cut one molecule into two; fumarase adds water across a double bond and leaves one molecule. Ask what happens to the bonds, not whether water appears.

Many enzymes cannot work alone. A **cofactor** is a small helper required for activity, of two kinds. A **coenzyme** is an organic molecule, usually derived from a vitamin (niacin becomes NAD⁺; thiamine becomes thiamine pyrophosphate (TPP)). A **metal ion** is the inorganic kind (Zn²⁺, Mg²⁺). When a cofactor, organic or metal, binds tightly and permanently rather than coming and going, we call it a **prosthetic group**; the heme buried in catalase, an organic ring holding an iron ion, is the classic example. The pair of terms that trips students up most: an enzyme missing its cofactor is an **apoenzyme** and it does not work; the assembled, working complex is the **holoenzyme**. Apo means away; holo means whole.

*Figure (AI-generated illustration).* Apoenzyme (cofactor missing, inactive) and holoenzyme (cofactor bound, active). NAD⁺ and FAD are both coenzymes; what differs is how tightly they bind. NAD⁺ comes and goes, while tightly bound FAD stays put and so counts as a prosthetic group. Image: an enzyme with an empty cleft and its cofactor outside is labelled inactive apoenzyme; the same enzyme with the cofactor seated is the active holoenzyme. Below, one inset shows NAD⁺ as a loosely bound coenzyme that binds, reacts and leaves; the other shows FAD locked into the cleft as a tightly bound prosthetic group.

The classifier below shows one reaction at a time.

*Interactive on the lesson page:* Classify the enzyme — by what it does to the bond

## Going deeper

### The bookkeeping behind the rule

The speed-up rule comes from a thermodynamic cycle: going from free substrate to bound transition state costs the same free energy whichever way round you go. It compares kcat with kuncat and assumes the same kind of transition state and the same frequency factor in both. Written for kcat/KM (free enzyme plus free substrate) instead, the same cycle measures how tightly the enzyme holds the transition state outright. That free-end speed-up is the one that is equal forward and reverse: (kcat/KM) forward over (kcat/KM) reverse equals Keq (the Haldane relation), which is why no enzyme can move the equilibrium.

It applies to the highest barrier of a multistep reaction, which has several transition states and intermediates (the 7TIM structure holds an intermediate analog). Once an enzyme is limited by how fast substrate diffuses in, as triosephosphate isomerase nearly is, extra grip on the chemical transition state no longer helps. And it does not cover coupling, which changes the reaction itself (the hexokinase answer above).

### Fischer, Haldane, Pauling and shape

Fischer called lock-and-key a hypothesis that could only be tested once someone could hold a pure enzyme and see its shape; when crystallographers finally did, many active sites turned out to flex. Shape changes also continue after the chemistry: in an induced-fit enzyme, the site reopens to help the product leave.

### The full class definitions and EC numbers

Hexokinase’s EC 2.7.1.1 reads as transferase, phosphate group, alcohol acceptor, first on the list. Strictly, EC 2.7 is “transferring phosphorus-containing groups”, so “phosphate group” is a fair gloss. The official lyase definition is broader than “add or remove groups across a double bond”: lyases break bonds by means other than hydrolysis or oxidation, often forming a double bond or a ring. The short version is enough for the MCAT.

### Statins and muscle symptoms

The classic worry: a patient starts a cholesterol drug and within weeks their muscles ache and a blood marker called creatine kinase (CK) climbs. The pathway statins slow also makes CoQ10 for mitochondrial energy and the isoprenoids muscle cells need. One proposed explanation for statin muscle symptoms is that blocking the pathway lowers CoQ10 and isoprenoids in muscle and harms its mitochondria. It is not proven. Other mechanisms are being studied, CoQ10 supplements have not reliably helped, and in blinded trials most muscle aches reported on statins also occur on placebo. True statin muscle damage with a large CK rise is rare.

---

From STEMhop (https://stemhop.com), free lessons by Christopher Deppmann. Lesson text © the authors. Practice questions: https://stemhop.com/lessons/enzyme-action-basics/
